Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2010
08/04/2010CN101058794B Method of constructing transfer cellulose enzyme gene saccharomyces cerevisiae
08/03/2010US7769440 Electromanipulation device and method
08/03/2010US7767889 Maize variety PHPCW
08/03/2010US7767888 Maize Hybrid variety X4T962
08/03/2010US7767887 Soybean variety D5123854
08/03/2010US7767886 Comprises restoration of fertility (RF) polypeptide comprising pentatricopeptide repeat (PPR) for restoring fertility to male sterile plants; genetic engineering and selective plant breeding
08/03/2010US7767885 Transgenic plant generated via transformation of non-green plant cells through plastid transformation; regeneration non-green plant cells through somatic embryogenesis; chloroplast genetic engineering and hyper-expression of vaccine antigens; producing valuable therapeutic proteins
08/03/2010US7767884 Method of repressing flowering in a plant
08/03/2010US7767881 Mixture of histamine receptor protein and histamine receptor antagonist
08/03/2010US7767880 Methods of screening agents for activity using teleosts
08/03/2010US7767879 Chimeric mouse for use as tool in identifying modulators for treatment and prevention of alzheimer's disease
08/03/2010US7767804 Recovering ribonucleic acid sequences from matrix; mixing biological material with buffered RNA lysing/binding solution; incubate with matrix; preferentially elute RNA from matrix; nucleic acid isolation
08/03/2010US7767802 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent
08/03/2010US7767801 Tissue specific promoters
08/03/2010US7767793 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases
08/03/2010US7767792 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy
08/03/2010US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
08/03/2010US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration
08/03/2010US7767653 Enhancement of immune response to vaccine by interferon alpha
08/03/2010US7767641 promoting endothelial cell adhesion, spreading and migration in treating a condition or disease characterized by pathological vascular remodeling in a subject in need thereof by administering a composition comprising Nogo-B or a fragment of Nogo-B comprising 1- 200 of the N-terminus
08/03/2010US7767456 Non-viral gene delivery system
08/03/2010US7767455 Nucleus export reporter system
08/03/2010US7767454 Generating genetic aberrations in splice acceptors which have phenotypic manifestations using nonhomologous recombination with plasmids, transposons or retroviruses
08/03/2010US7767451 Cultured feline fetal tissue generated in absence of mammalian polypeptides for use as bioreactor in production of inexpensive feline vaccine
08/03/2010US7767450 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders
08/03/2010US7767449 Methods using modified vaccinia virus
08/03/2010US7767435 Method and device for biochemical detection and analysis of subcellular compartments from a single cell
08/03/2010US7767431 Transgenic microorganism for use as bioreator for synthesis of amino acids to be use in animal feeds and pharmaceuticals
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767428 Nucleotide sequences coding transferase for use in production of thebaine
08/03/2010US7767424 Cloning and characterization of the broad-spectrum resistance gene PI2
08/03/2010US7767420 Using bacteroides thetaiotaomicron gag lyase to specifically cleave heparin or heparan; treating arthritic, inflammatory, angiogenic and eye disorders
08/03/2010US7767419 Calibrator for NT-proBNP immunoassay
08/03/2010US7767418 Expression vector comprising nucleotide sequences coding immunoglobulin fusion comprising transient receptor potential cation channel for use in identifying modulator for treatment and prevention of nervous system disorders
08/03/2010US7767416 Expression vector comprising nucleotide sequences coding flavonoid biosynthetic enzymes for use as tool in enhancing resistance to abiotic stress and modifying forage quality of plants
08/03/2010US7767405 Using glycosphingolipid GD2 specific immunoglobulin to treat cell proliferative disorders; immunotherapy; tissue targeted therapy
08/03/2010US7767403 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer
08/03/2010US7767398 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders
08/03/2010US7767397 Hepoxilins and modulators of ichthyin for treatment skin disorders
08/03/2010US7767393 Classifying and characterizing prostate gland tissues via monitoring expression of tumor markers such as hepsin; for diagnosing prostate/urogenital health; kits
08/03/2010US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
08/03/2010US7767209 Modified vaccinia virus Ankara (MVA) mutant and use thereof
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010US7767205 Erythropoietin-producing hepatocellullar kinase (EPH) specific immunoglobulin for use in treatment and prevention of tumor, cancer and/or cell proliferative disorders
08/03/2010US7767201 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
08/03/2010CA2480646C Detection of dna-binding proteins
08/03/2010CA2468295C Glycoprotein remodeling using endoglycanases
08/03/2010CA2412183C Rtvp based compositions and methods for the treatment of prostate cancer
08/03/2010CA2409432C Modified morbillivirus v proteins
08/03/2010CA2401342C Human antibodies against eotaxin and their use
08/03/2010CA2353603C Udp-n- acetyl glucosamine: galactose-.beta.1, 3-n- acetyl galactosamine- .alpha.-r/ n- acetyl glucosamine -.beta.1, 3-n- acetyl galactosamine- .alpha.-r (glcnac to galnac) .beta.1,6-n- acetyl glucosaminyl transferase, c2/4gnt
08/03/2010CA2345905C Plant-optimized polynucleotides encoding approximately 15 kda and approximately 45 kda pesticidal proteins
08/03/2010CA2283629C Fluorescent protein sensors for detection of analytes
08/03/2010CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
08/03/2010CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
08/03/2010CA2224777C New immunoregulatory protein lst-1
08/03/2010CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
08/03/2010CA2178057C Epstein-barr virus peptides and antibodies against these peptides
08/03/2010CA2133873C Tnf inhibitors
08/03/2010CA2097803C Recombinant cells that highly express chromosomally-integrated heterologous genes
07/2010
07/29/2010WO2010085731A2 Production of 1,4 butanediol in a microorganism
07/29/2010WO2010085699A2 Mammalian piggybac transposon and methods of use
07/29/2010WO2010085555A1 Methods for expansion of hematopoietic stem and progenitor cells
07/29/2010WO2010085373A2 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010WO2010085295A2 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010WO2010085289A1 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010WO2010085213A1 SINGLE NUCLEOTIDE POLYMORPHISM WITHIN AN INTRONIC p53 BINDING MOTIF OF THE PRKAG2 GENE
07/29/2010WO2010085162A2 Expression cassettes, T-DNA molecules, plant expression vectors, transgenic plant cells as well as the use thereof in the production of a vaccine
07/29/2010WO2010085151A2 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
07/29/2010WO2010085124A2 Marker for liver-cancer diagnosis and recurrence and survival prediction, a kit comprising the same, and prognosis prediction in liver-cancer patients using the marker
07/29/2010WO2010085114A2 Abscisic acid carrier gene and transgenic plant expressing same
07/29/2010WO2010085101A2 Novel lipases induced by fasting
07/29/2010WO2010085086A2 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
07/29/2010WO2010085012A1 Method for secreting and producing foreign protein in e. coli
07/29/2010WO2010084970A1 Feeder cell for target cell induction
07/29/2010WO2010084969A1 Novel promoter for use in transformation of algae
07/29/2010WO2010084947A1 Process for producing heterologous polypeptide
07/29/2010WO2010084879A1 Flavonoid-3-glucuronyltransferase and polynucleotide encoding same
07/29/2010WO2010084851A1 Peptide capable of binding to immunoglobulin
07/29/2010WO2010084798A1 Tricyclic compound
07/29/2010WO2010084668A1 Diagnostic method for nephrotic syndrome, prophylactic or therapeutic agent for nephrotic syndrome, and method for screening the prophylactic or therapeutic agent
07/29/2010WO2010084488A1 Mir-21 promoter driven targeted cancer therapy
07/29/2010WO2010084371A1 Novel circular interfering rna molecules
07/29/2010WO2010084349A1 Method of double crossover homologous recombination in clostridia
07/29/2010WO2010084331A2 Gene targeting in plants
07/29/2010WO2010084275A1 Simplified method for partial genetic and epigenetic reprogramming of cells
07/29/2010WO2010084231A1 Genetic construction comprising the gene encoding the kap protein and non-human animal genetically modified therewith
07/29/2010WO2010084181A1 Methods for generation of rna and (poly)peptide libraries and their use
07/29/2010WO2010084171A1 Method for temporally controlling the biological activity of proteins in vertebrates, and applications thereof
07/29/2010WO2010083844A1 Methods and uses for rna extract and storage
07/29/2010WO2010083842A2 Expression of neuropeptides in mammalian cells
07/29/2010WO2010083841A2 Improved cell lines and their use in encapsulated cell biodelivery
07/29/2010WO2010083615A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010WO2010083561A1 Improved isothermal strand displacement amplification
07/29/2010WO2010062480A3 Methods and compositions for producing fatty alcohols
07/29/2010WO2010061187A3 Method for the transformation of plant cell mitochondria
07/29/2010WO2010060964A3 Cellulase cel5h related reagents and their use in microorganisms
07/29/2010WO2010060934A3 Cnnm proteins and uses thereof
07/29/2010WO2010059539A3 Genetically engineered yeast for the production of biofuels
1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 4023